Emyria Ltd (ASX:EMD) managing director Michael Winlo joins Proactive to discuss the healthcare stock’s Pax Centre acquisition. The move brings a top-tier clinical service — specialising in comprehensive psychological trauma care — into the EMD fold, expanding its capabilities as it develops a pipeline of MDMA-assisted therapies. Winlo says the acquisition will be transformative, strengthening Emyria’s clinical service foundations as it builds a care-centric model for delivering mental health treatments.
Emyria expands mental health care capabilities with Pax Centre acquisition
